Articles:
Publications:

3 hours ago

Island Pharma drug cleared for Bundibugyo Ebola use

Island Pharma drug cleared for Bundibugyo Ebola use

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the Bundibugyo Ebola outbreak in Uganda. The Melbourne, Australia-based biotech said it expects galidesivir to be deployed in... Read more.

More from pharmaphorum

pharmaphorum 3 hours ago
Turn on Transparency.
With measles cases rising, UK launches vaccination drive
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO) More info
pharmaphorum 3 hours ago
Turn on Transparency.
Obesity biotech Kalohexis files confidential IPO
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO) More info
pharmaphorum 3 hours ago
Turn on Transparency.
Island Pharma drug cleared for Bundibugyo Ebola use
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO) More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

12 hours ago
AFP Journalists in Turkey Go on Strike Over Pay as Union Cites Inflation Gap
Neutral | Owner: International Journalists Association
12 hours ago
Kuwait Steps up Battle Against AI-Driven Misinformation
Center-left | Owner: Ahmed Al-Jarallah
12 hours ago
Journalists Turn to Courts to Combat Censorship Fears After Senate Abandons Modern Press Freedom Framework in the Dominican Republic
Neutral | Owner: Dolores Vicioso

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more